1. PSA Drop Seen with New Prostate Ca Drug. Half of a group of men with castration-resistant prostate cancer (CRPC) had biochemical responses to treatment with an investigational androgen receptor modulator.
2. ACA Gets Its Three Days in Supreme Court. It was a historic week in the nation’s capital as the Supreme Court heard oral arguments on four separate but intertwined issues regarding the constitutionality of the landmark Affordable Care Act (ACA).
3. MS and Quality of Life, a Clinical Context Report. What happens when a patient with MS sees the doctor is, very frequently, you know, the doctor has a treatment algorithm — you do this, this, and this for a patient with multiple sclerosis, and okay, we’re done, get out of here — and I’m sure that’s not satisfying to the patient and is really not treating what the patient needs.